<p>根据 Regal Partners Ltd 最近向证券交易委员会提交的文件，该公司在第三季度购买了 Inspire Medical Systems, Inc.（纽约证券交易所代码：INSP - 免费报告）的新股份。该公司购买了 101,714 股该公司的股票，价值约为 7,547,000 美元。Inspire Medical Systems 占 Regal Partners Ltd 投资组合的约 0.5%，使其成为该公司第 26 大持仓。截至最近向证券交易委员会提交的文件，Regal Partners Ltd 持有 Inspire Medical Systems 的 0.35%。</p>
<ul>
<li>艾利 Lilly 股票上涨：GLP-1 Zepbound 目标睡眠呼吸暂停市场</li>
</ul>
<p>其他机构投资者最近也买卖了该公司的股票。德克萨斯州永久学校基金公司在第二季度将其在 Inspire Medical Systems 的股份增加了 42.2%。德克萨斯州永久学校基金公司现在拥有 40,042 股该公司的股票，价值 5,196,000 美元，在此期间又收购了 11,892 股。Y Intercept Hong Kong Ltd 在第三季度将其在 Inspire Medical Systems 的股份增加了 553.1%。Y Intercept Hong Kong Ltd 现在拥有 99,049 股该公司的股票，价值 7,349,000 美元，在此期间又收购了 83,883 股。CW Advisors LLC 在第二季度将其在 Inspire Medical Systems 的股份增加了 45.3%。CW Advisors LLC 现在拥有 49,960 股该公司的股票，价值 6,484,000 美元，在此期间又收购了 15,576 股。Capital Fund Management S.A.在第二季度将其在 Inspire Medical Systems 的持股增加了 44.1%。Capital Fund Management S.A.现在拥有 68,663 股该公司的股票，价值 8,910,000 美元，在上个季度又购买了 21,021 股。最后，挪威银行在第二季度收购了 Inspire Medical Systems 的新股份，价值 31,066,000 美元。机构投资者和对冲基金持有该公司 94.91% 的股票。</p>
<h2>Inspire Medical Systems 股票表现</h2>
<p>INSP 股票在周五开盘价为 63.01 美元。Inspire Medical Systems, Inc.的 52 周低点为 53.11 美元，52 周高点为 189.49 美元。该公司的市值为 18 亿美元，市盈率为 12.65，市盈率增长比率为 3.09，贝塔值为 0.74。该公司的 50 日简单移动平均线为 77.16 美元，200 日简单移动平均线为 87.18 美元。</p>
<ul>
<li>Inspire Medical 在突破后上涨 15%，分析师称其为买入</li>
</ul>
<p>Inspire Medical Systems（纽约证券交易所代码：INSP - 获取免费报告）最近在 2 月 11 日星期三发布了季度财报。该公司报告每股收益为 1.65 美元，超出市场共识预期的 0.69 美元，超出 0.96 美元。该公司在该季度的收入为 2.6908 亿美元，而分析师预期为 2.6402 亿美元。Inspire Medical Systems 的净利润率为 15.95%，股本回报率为 10.96%。该公司的收入同比增长 12.2%。在去年同期，该公司每股收益为 1.15 美元。分析师预计 Inspire Medical Systems, Inc.在当前年度将发布 2.16 美元的每股收益。</p>
<h2>分析师评级变动</h2>
<p>几位股票分析师对 INSP 股票发表了评论。摩根士丹利在 2 月 18 日星期三的报告中对 Inspire Medical Systems 的股票设定了 60.00 美元的目标价。Oppenheimer 在 1 月 22 日星期四的报告中将 Inspire Medical Systems 的股票评级从 “跑赢大盘” 下调至 “市场表现”。Weiss Ratings 在 12 月 29 日星期一的研究报告中重申了对 Inspire Medical Systems 的 “卖出（d）” 评级。Stifel Nicolaus 在周四的研究报告中将 Inspire Medical Systems 的目标价从 95.00 美元下调至 85.00 美元，并对该公司设定了 “买入” 评级。最后，富国银行在 2 月 12 日星期四的研究报告中对 Inspire Medical Systems 设定了 70.00 美元的目标价，并给予该公司 “等权重” 评级。五位投资分析师对该股票给予了买入评级，十三位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价为 104.24 美元。</p>
<ul>
<li>小型股是否预示市场下跌？</li>
</ul>
<p><strong>查看我们关于 INSP 的最新报告</strong></p>
<h2>关于 Inspire Medical Systems</h2>
<p>（免费报告）</p>
<p>Inspire Medical Systems, Inc 是一家医疗技术公司，专注于用于治疗阻塞性睡眠呼吸暂停（OSA）的可植入神经刺激设备。该公司的旗舰产品 Inspire®系统，通过对舌下神经的定向刺激，保持睡眠期间气道通畅，为对持续正压呼吸机（CPAP）设备不耐受或管理不当的患者提供替代疗法。</p>
<p>Inspire 系统由一个可植入的脉冲发生器、一个监测呼吸模式的传感导线和一个激活舌下神经的刺激导线组成。</p>
<h2>另见</h2>
<ul>
<li>五只我们更看好的股票，胜过 Inspire Medical Systems</li>
<li>摩根大通 8000 美元的黄金看涨期权将使大多数退休账户落后</li>
<li>白银是新的石油——世界正在枯竭</li>
<li>英伟达首席执行官发出大胆的特斯拉呼吁</li>
<li>埃隆的最大突破？</li>
<li>这让我感到愤怒</li>
</ul>
<p><strong>想看看其他对冲基金持有 INSP 的情况吗？</strong> 访问 HoldingsChannel.com，获取 Inspire Medical Systems, Inc.（纽约证券交易所代码：INSP - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Inspire Medical Systems 吗？</h2>
<p>在考虑 Inspire Medical Systems 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而启迪医疗并不在名单上。</p>
<p>虽然启迪医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

标普生物技术 ETF - SPDR

动态生物技术与基因组 ETF - Invesco

2 倍做多纳斯达克生物技术 ETF - ProShares

纽交所高增长板生物技术指数 ETF - First Trust

医药突破 ETF - ALPS

启迪医疗

生物科技 ETF - VanEck Vectors

纳斯达克生物科技指数 ETF - iShares Nasdaq

美国医药设备 ETF - iShares

标普健康医疗设备 ETF - SPDR

<p>Regal Partners Ltd 已在 Inspire Medical Systems, Inc.（纽约证券交易所代码：INSP）中获得了一个新头寸，购买了 101,714 股，价值约 750 万美元，使其成为该投资组合中第 26 大的头寸。其他机构投资者也增加了对 Inspire Medical Systems 的持股。该公司的股票开盘价为 63.01 美元，市值为 18 亿美元，市盈率为 12.65。分析师对该股票的评级不一，平均评级为 “持有”，共识目标价为 104.24 美元</p>

<p>Regal Partners Ltd purchased a new position in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the third quarter, according to the company in its most recent filing with the Securities &amp; Exchange Commission. The firm purchased 101,714 shares of the company's stock, valued at approximately $7,547,000. Inspire Medical Systems accounts for approximately 0.5% of Regal Partners Ltd's investment portfolio, making the stock its 26th largest position. Regal Partners Ltd owned 0.35% of Inspire Medical Systems as of its most recent filing with the Securities &amp; Exchange Commission.</p>
<div class="lb-trans"><p>根据 Regal Partners Ltd 最近向证券交易委员会提交的文件，该公司在第三季度购买了 Inspire Medical Systems, Inc.（纽约证券交易所代码：INSP - 免费报告）的新股份。该公司购买了 101,714 股该公司的股票，价值约为 7,547,000 美元。Inspire Medical Systems 占 Regal Partners Ltd 投资组合的约 0.5%，使其成为该公司第 26 大持仓。截至最近向证券交易委员会提交的文件，Regal Partners Ltd 持有 Inspire Medical Systems 的 0.35%。</p>
</div><ul>
<li>Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market</li>
</ul>
<div class="lb-trans"><ul>
<li>艾利 Lilly 股票上涨：GLP-1 Zepbound 目标睡眠呼吸暂停市场</li>
</ul>
</div><p>Other institutional investors have also recently bought and sold shares of the company. Texas Permanent School Fund Corp boosted its stake in shares of Inspire Medical Systems by 42.2% during the 2nd quarter. Texas Permanent School Fund Corp now owns 40,042 shares of the company's stock worth $5,196,000 after acquiring an additional 11,892 shares during the period. Y Intercept Hong Kong Ltd raised its stake in Inspire Medical Systems by 553.1% in the 3rd quarter. Y Intercept Hong Kong Ltd now owns 99,049 shares of the company's stock valued at $7,349,000 after acquiring an additional 83,883 shares during the period. CW Advisors LLC raised its stake in Inspire Medical Systems by 45.3% in the 2nd quarter. CW Advisors LLC now owns 49,960 shares of the company's stock valued at $6,484,000 after acquiring an additional 15,576 shares during the period. Capital Fund Management S.A. lifted its holdings in Inspire Medical Systems by 44.1% during the 2nd quarter. Capital Fund Management S.A. now owns 68,663 shares of the company's stock valued at $8,910,000 after purchasing an additional 21,021 shares during the last quarter. Finally, Norges Bank acquired a new stake in Inspire Medical Systems during the 2nd quarter valued at $31,066,000. Institutional investors and hedge funds own 94.91% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者最近也买卖了该公司的股票。德克萨斯州永久学校基金公司在第二季度将其在 Inspire Medical Systems 的股份增加了 42.2%。德克萨斯州永久学校基金公司现在拥有 40,042 股该公司的股票，价值 5,196,000 美元，在此期间又收购了 11,892 股。Y Intercept Hong Kong Ltd 在第三季度将其在 Inspire Medical Systems 的股份增加了 553.1%。Y Intercept Hong Kong Ltd 现在拥有 99,049 股该公司的股票，价值 7,349,000 美元，在此期间又收购了 83,883 股。CW Advisors LLC 在第二季度将其在 Inspire Medical Systems 的股份增加了 45.3%。CW Advisors LLC 现在拥有 49,960 股该公司的股票，价值 6,484,000 美元，在此期间又收购了 15,576 股。Capital Fund Management S.A.在第二季度将其在 Inspire Medical Systems 的持股增加了 44.1%。Capital Fund Management S.A.现在拥有 68,663 股该公司的股票，价值 8,910,000 美元，在上个季度又购买了 21,021 股。最后，挪威银行在第二季度收购了 Inspire Medical Systems 的新股份，价值 31,066,000 美元。机构投资者和对冲基金持有该公司 94.91% 的股票。</p>
</div><h2>Inspire Medical Systems Stock Performance</h2>
<div class="lb-trans"><h2>Inspire Medical Systems 股票表现</h2>
</div><p>INSP stock opened at $63.01 on Friday. Inspire Medical Systems, Inc. has a 52 week low of $53.11 and a 52 week high of $189.49. The company has a market capitalization of $1.80 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 3.09 and a beta of 0.74. The company's 50-day simple moving average is $77.16 and its 200 day simple moving average is $87.18.</p>
<div class="lb-trans"><p>INSP 股票在周五开盘价为 63.01 美元。Inspire Medical Systems, Inc.的 52 周低点为 53.11 美元，52 周高点为 189.49 美元。该公司的市值为 18 亿美元，市盈率为 12.65，市盈率增长比率为 3.09，贝塔值为 0.74。该公司的 50 日简单移动平均线为 77.16 美元，200 日简单移动平均线为 87.18 美元。</p>
</div><ul>
<li>Inspire Medical Up 15% After Breakout, Analysts Say It's A Buy</li>
</ul>
<div class="lb-trans"><ul>
<li>Inspire Medical 在突破后上涨 15%，分析师称其为买入</li>
</ul>
</div><p>Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $1.65 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.96. The business had revenue of $269.08 million during the quarter, compared to analysts' expectations of $264.02 million. Inspire Medical Systems had a net margin of 15.95% and a return on equity of 10.96%. The business's revenue was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.15 EPS. On average, analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.</p>
<div class="lb-trans"><p>Inspire Medical Systems（纽约证券交易所代码：INSP - 获取免费报告）最近在 2 月 11 日星期三发布了季度财报。该公司报告每股收益为 1.65 美元，超出市场共识预期的 0.69 美元，超出 0.96 美元。该公司在该季度的收入为 2.6908 亿美元，而分析师预期为 2.6402 亿美元。Inspire Medical Systems 的净利润率为 15.95%，股本回报率为 10.96%。该公司的收入同比增长 12.2%。在去年同期，该公司每股收益为 1.15 美元。分析师预计 Inspire Medical Systems, Inc.在当前年度将发布 2.16 美元的每股收益。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several equities analysts have commented on INSP shares. Morgan Stanley set a $60.00 price objective on shares of Inspire Medical Systems in a report on Wednesday, February 18th. Oppenheimer downgraded shares of Inspire Medical Systems from an &#34;outperform&#34; rating to a &#34;market perform&#34; rating in a report on Thursday, January 22nd. Weiss Ratings reiterated a &#34;sell (d)&#34; rating on shares of Inspire Medical Systems in a research note on Monday, December 29th. Stifel Nicolaus cut their price objective on shares of Inspire Medical Systems from $95.00 to $85.00 and set a &#34;buy&#34; rating for the company in a research report on Thursday. Finally, Wells Fargo &amp; Company set a $70.00 target price on Inspire Medical Systems and gave the company an &#34;equal weight&#34; rating in a research report on Thursday, February 12th. Five investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and a consensus price target of $104.24.</p>
<div class="lb-trans"><p>几位股票分析师对 INSP 股票发表了评论。摩根士丹利在 2 月 18 日星期三的报告中对 Inspire Medical Systems 的股票设定了 60.00 美元的目标价。Oppenheimer 在 1 月 22 日星期四的报告中将 Inspire Medical Systems 的股票评级从 “跑赢大盘” 下调至 “市场表现”。Weiss Ratings 在 12 月 29 日星期一的研究报告中重申了对 Inspire Medical Systems 的 “卖出（d）” 评级。Stifel Nicolaus 在周四的研究报告中将 Inspire Medical Systems 的目标价从 95.00 美元下调至 85.00 美元，并对该公司设定了 “买入” 评级。最后，富国银行在 2 月 12 日星期四的研究报告中对 Inspire Medical Systems 设定了 70.00 美元的目标价，并给予该公司 “等权重” 评级。五位投资分析师对该股票给予了买入评级，十三位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价为 104.24 美元。</p>
</div><ul>
<li>Are Small Caps a Harbinger of Market Declines?</li>
</ul>
<div class="lb-trans"><ul>
<li>小型股是否预示市场下跌？</li>
</ul>
</div><p><strong>Check Out Our Latest Report on INSP</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 INSP 的最新报告</strong></p>
</div><h2>About Inspire Medical Systems</h2>
<div class="lb-trans"><h2>关于 Inspire Medical Systems</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.</p>
<div class="lb-trans"><p>Inspire Medical Systems, Inc 是一家医疗技术公司，专注于用于治疗阻塞性睡眠呼吸暂停（OSA）的可植入神经刺激设备。该公司的旗舰产品 Inspire®系统，通过对舌下神经的定向刺激，保持睡眠期间气道通畅，为对持续正压呼吸机（CPAP）设备不耐受或管理不当的患者提供替代疗法。</p>
</div><p>The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.</p>
<div class="lb-trans"><p>Inspire 系统由一个可植入的脉冲发生器、一个监测呼吸模式的传感导线和一个激活舌下神经的刺激导线组成。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Inspire Medical Systems</li>
<li>How JPMorgan's $8,000 Gold Call Will Leave Most Retirement Accounts Behind</li>
<li>Silver Is the New Oil—And the World’s Running Dry</li>
<li>Nvidia CEO Issues Bold Tesla Call</li>
<li>Elon’s BIGGEST breakthrough yet?</li>
<li>This makes me furious</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Inspire Medical Systems</li>
<li>摩根大通 8000 美元的黄金看涨期权将使大多数退休账户落后</li>
<li>白银是新的石油——世界正在枯竭</li>
<li>英伟达首席执行官发出大胆的特斯拉呼吁</li>
<li>埃隆的最大突破？</li>
<li>这让我感到愤怒</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding INSP?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有 INSP 的情况吗？</strong> 访问 HoldingsChannel.com，获取 Inspire Medical Systems, Inc.（纽约证券交易所代码：INSP - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUlOU1A" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=INSP"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Inspire Medical Systems Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Inspire Medical Systems 吗？</h2>
</div><p>Before you consider Inspire Medical Systems, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Inspire Medical Systems 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而启迪医疗并不在名单上。</p>
</div><p>While Inspire Medical Systems currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然启迪医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Regal Partners Ltd Buys New Holdings in Inspire Medical Systems, Inc. $INSP

Market Beat

Regal Partners Ltd 购入了启迪医疗系统公司（Inspire Medical Systems, Inc.）的新股份 $INSP